cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
AA215957 | .a | 830 to 1076 | 1 to 256 | 256/260 (98 %) | 12 diff (95.4 %id) | ||||
AA299774 | uterus | .a | 1014 to 1201 | 1 to 188 | 188/188 (100 %) | 1 diff (99.5 %id) | |||
AA299775 | uterus | .a | 1014 to 1201 | 188 to 1 | 188/196 (95 %) | 0 diff (100 %id) | |||
AA318055 | retina | .a | 45 to 186 | 1 to 143 | 143/143 (100 %) | 2 diff (98.7 %id) | |||
AA369824 | Prostate | .a | 849 to 1126 | 1 to 280 | 280/280 (100 %) | 4 diff (98.6 %id) | |||
AF117959 | .a | 28 to 1194 | 1 to 1166 | T31A | AAA | 1166/1166 (100 %) | 8 diff (99.4 %id) | ||
AF366402 | .a | 45 to 1201 | 1 to 1155 | T31A | AAA | 1155/1155 (100 %) | 6 diff (99.5 %id) | ||
AK074652 | mammary gland | .a | 1 to 2113 | 2 to 2113 | exact | tiling clone, available from FLJ, | 2113/2113 (100 %) | 2 diff (100.0 %id) | |
AK222970 | human small intestine | .a | 33 to 1142 | 1 to 1110 | exact | 1110/1110 (100 %) | 1 diff (100.0 %id) | ||
AK223011 | human small intestine | .a | 33 to 1135 | 1 to 1103 | exact | 1103/1103 (100 %) | 1 diff (100.0 %id) | ||
AW957102 | .a | 850 to 1201 | 1 to 352 | AAA | 352/352 (100 %) | 0 diff (100 %id) | |||
BC002670 | Uterus, endometrium adenocarcinoma | .a | 51 to 1201 | 1 to 1151 | exact | available from MGC, AAA | 1151/1151 (100 %) | 1 diff (100.0 %id) | |
BF917786 | uterus_tumor | .a | 176 to 708 | 1 to 531 | 531/531 (100 %) | 6 diff (98.9 %id) | |||
BG896894 | cartilage | .a | 43 to 573 | 76 to 604 | 529/546 (96 %) | 10 diff (98.2 %id) | |||
BG981025 | colon_normal | .a | 915 to 1201 | 14 to 300 | AAA | 287/300 (95 %) | 6 diff (98.0 %id) | ||
BX101521 | ovarian tumor, ovary | .a | 331 to 1126 | 1 to 797 | 797/797 (100 %) | 2 diff (99.8 %id) | |||
CN304598 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 108 to 645 | 1 to 538 | 538/538 (100 %) | 2 diff (99.7 %id) | |||
CN304599 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 82 to 504 | 1 to 423 | 423/423 (100 %) | 1 diff (99.8 %id) | |||
CN304600 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .a | 39 to 523 | 1 to 485 | 485/485 (100 %) | 3 diff (99.4 %id) | |||
CN304601 | embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 | .a | 55 to 443 | 1 to 389 | AAA | 389/409 (95 %) | 7 diff (98.3 %id) | ||
CV026226 | mixed | .a | 159 to 714 | 1 to 556 | 556/556 (100 %) | 12 diff (97.9 %id) | |||
EC491944 | Prostate | .a | 616 to 710 | 95 to 1 | 95/95 (100 %) | 0 diff (100 %id) | |||
EC499691 | Prostate | .a | 616 to 704 | 98 to 10 | 89/98 (90 %) | 0 diff (100 %id) | |||
EC515310 | Prostate | .a | 616 to 710 | 95 to 1 | 95/95 (100 %) | 0 diff (100 %id) | |||
EC535772 | Prostate | .a | 616 to 702 | 104 to 19 | 86/104 (82 %) | 0 diff (100 %id) | |||
EL946124 | eyeball | .a | 856 to 1137 | 1 to 285 | 285/285 (100 %) | 10 diff (96.5 %id) | |||
BG939631 | bone marrow stroma | .a | 791 to 1201 | 450 to 40 | AAA | 411/411 (100 %) | 0 diff (100 %id) | ||
BP387701 | pancreatic islet | .a | 926 to 1203 | 1 to 279 | Submitted on the opposite strand | 279/279 (100 %) | 5 diff (98.3 %id) | ||
BP260962 | small intestine | .a | 33 to 616 | 1 to 584 | 584/584 (100 %) | 2 diff (99.7 %id) | |||
BP263952 | small intestine | .a | 33 to 614 | 1 to 582 | 582/582 (100 %) | 3 diff (99.5 %id) | |||
N31928 | melanocyte | .a | 623 to 1202 | 579 to 1 | 579/579 (100 %) | 6 diff (99.0 %id) | |||
N42765 | melanocyte | .a | 159 to 374 | 1 to 217 | 217/217 (100 %) | 4 diff (98.2 %id) | |||
W52056 | Pancreas, pancreatic islet | .a | 52 to 409 | 1 to 364 | 364/364 (100 %) | 11 diff (97.0 %id) | |||
W60601 | Pancreas, pancreatic islet | .a | 749 to 1204 | 464 to 3 | 462/464 (99 %) | 0 diff (100 %id) | |||
AA719658 | pineal gland | .a | 1112 to 1200 | 89 to 1 | 89/89 (100 %) | 0 diff (100 %id) | |||
AA031531 | uterus | .a | 523 to 752 | 1 to 225 | fully sequenced, | 225/225 (100 %) | 7 diff (96.9 %id) | ||
AA031532 | uterus | .a | 723 to 1201 | 497 to 18 | fully sequenced, AAA | 480/480 (100 %) | 6 diff (98.8 %id) | ||
AA292940 | ovarian tumor, ovary | .a | 331 to 719 | 1 to 384 | 384/384 (100 %) | 11 diff (97.2 %id) | |||
AA293448 | ovarian tumor, ovary | .a | 763 to 1202 | 440 to 1 | 440/440 (100 %) | 3 diff (99.4 %id) | |||
AA293515 | ovarian tumor, ovary | .a | 331 to 762 | 1 to 424 | 424/424 (100 %) | 11 diff (97.5 %id) | |||
AA480086 | ovarian tumor, ovary | .a | 331 to 846 | 1 to 520 | fully sequenced, | 520/520 (100 %) | 8 diff (98.5 %id) | ||
AA481995 | ovarian tumor, ovary | .a | 816 to 1200 | 385 to 1 | fully sequenced, | 385/385 (100 %) | 2 diff (99.5 %id) | ||
AA487786 | lung | .a | 869 to 1203 | 332 to 1 | Submitted on the opposite strand | 332/332 (100 %) | 5 diff (98.5 %id) | ||
AA573840 | colon, tumor | .a | 721 to 1204 | 482 to 2 | 481/482 (99 %) | 0 diff (100 %id) | |||
AA641041 | invasive tumor (cell line), Prostate | .a | 640 to 1201 | 563 to 1 | 563/563 (100 %) | 5 diff (99.2 %id) | |||
AA642241 | invasive tumor (cell line), Prostate | .a | 829 to 1107 | 279 to 1 | 279/279 (100 %) | 0 diff (100 %id) | |||
AA865888 | Kidney | .a | 856 to 1204 | 351 to 3 | 349/351 (99 %) | 0 diff (100 %id) | |||
AA887473 | Kidney | .a | 791 to 1204 | 415 to 3 | 413/415 (99 %) | 0 diff (100 %id) | |||
AA928491 | adenocarcinoma, colon | .a | 999 to 1201 | 214 to 12 | AAA | 203/203 (100 %) | 0 diff (100 %id) | ||
AI038825 | senescent fibroblast | .a | 851 to 1204 | 356 to 3 | 354/356 (99 %) | 0 diff (100 %id) | |||
AI038918 | senescent fibroblast | .a | 872 to 1204 | 336 to 4 | 333/336 (99 %) | 0 diff (100 %id) | |||
AI143781 | heart | .a | 806 to 1201 | 410 to 15 | AAA | 396/396 (100 %) | 1 diff (99.8 %id) | ||
AI262631 | adenocarcinoma, colon | .a | 859 to 1201 | 354 to 12 | AAA | 343/343 (100 %) | 1 diff (99.8 %id) | ||
AI262651 | adenocarcinoma, colon | .a | 1044 to 1204 | 166 to 6 | 161/166 (96 %) | 0 diff (100 %id) | |||
AI280925 | adenocarcinoma, colon | .a | 1011 to 1198 | 194 to 7 | 188/194 (96 %) | 0 diff (100 %id) | |||
AI342377 | uterus | .a | 530 to 1201 | 672 to 1 | 672/674 (99 %) | 8 diff (98.9 %id) | |||
AI366075 | brain, meningioma | .a | 811 to 1201 | 391 to 1 | 391/391 (100 %) | 2 diff (99.5 %id) | |||
AI560942 | anaplastic oligodendroglioma, brain | .a | 738 to 1201 | 463 to 1 | 463/463 (100 %) | 1 diff (99.8 %id) | |||
AI659129 | Prostate | .a | 918 to 1202 | 285 to 1 | 285/285 (100 %) | 0 diff (100 %id) | |||
AI963840 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .a | 852 to 1202 | 386 to 36 | AAA | 351/351 (100 %) | 11 diff (96.9 %id) | ||
AI955492 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .a | 1097 to 1201 | 120 to 16 | AAA | 105/105 (100 %) | 0 diff (100 %id) | ||
AW071086 | thymus, pooled | .a | 733 to 1202 | 470 to 1 | 470/470 (100 %) | 0 diff (100 %id) | |||
AI983548 | brain, three pooled meningiomas | .a | 745 to 1201 | 476 to 20 | AAA | 457/457 (100 %) | 5 diff (99.0 %id) | ||
AW129354 | serous papillary carcinoma, high grade, 2pooled tumors, uterus | .a | 745 to 1204 | 461 to 2 | 460/461 (99 %) | 0 diff (100 %id) | |||
AW188801 | moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus | .a | 1030 to 1197 | 171 to 3 | 169/171 (98 %) | 0 diff (100 %id) | |||
AW291243 | .a | 676 to 1201 | 543 to 18 | AAA | 526/526 (100 %) | 5 diff (99.1 %id) | |||
AW514511 | uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors | .a | 874 to 1201 | 329 to 1 | 329/329 (100 %) | 4 diff (98.8 %id) | |||
AW629185 | pooled | .a | 671 to 1201 | 545 to 15 | AAA | 531/531 (100 %) | 2 diff (99.7 %id) | ||
BE271936 | adenocarcinoma cell line, ovary | .a | 316 to 1004 | 1 to 685 | 685/688 (99 %) | 21 diff (97.0 %id) | |||
BE501947 | Kidney | .a | 664 to 1203 | 540 to 1 | 540/540 (100 %) | 1 diff (99.9 %id) | |||
BE391459 | endometrium, adenocarcinoma cell line, uterus | .a | 69 to 694 | 1 to 644 | 644/645 (99 %) | 20 diff (96.9 %id) | |||
BE613003 | adenocarcinoma, ovary | .a | 453 to 1093 | 1 to 638 | 638/638 (100 %) | 10 diff (98.5 %id) | |||
BE613164 | adenocarcinoma, ovary | .a | 452 to 1151 | 701 to 2 | 700/701 (99 %) | 0 diff (100 %id) | |||
BF032665 | adenocarcinoma, ovary | .a | 301 to 997 | 1 to 693 | 693/787 (88 %) | 21 diff (97.4 %id) | |||
BE898247 | adenocarcinoma cell line, ovary | .a | 157 to 980 | 11 to 820 | T31A S42L S43A S44P L45S ... | 810/876 (92 %) | 24 diff (97.3 %id) | ||
BE898853 | adenocarcinoma cell line, ovary | .a | 567 to 1204 | 1 to 637 | 637/655 (97 %) | 3 diff (99.6 %id) | |||
BF185725 | brain, glioblastoma | .a | 32 to 678 | 1 to 630 | 630/840 (75 %) | 18 diff (97.9 %id) | |||
BF666761 | brain, primitive neuroectoderm | .a | 32 to 664 | 1 to 621 | 621/621 (100 %) | 18 diff (97.2 %id) | |||
BG402912 | bladder, transitional cell papilloma, cell line | .a | 30 to 887 | 1 to 851 | T31A D167G D168R G169W L170A ... | 851/1037 (82 %) | 28 diff (97.3 %id) | ||
BG341629 | B-cells, primary B-cells from tonsils (cell line) | .a | 713 to 1201 | 1 to 489 | AAA | 489/489 (100 %) | 1 diff (99.8 %id) | ||
BG468137 | adenocarcinoma cell line, colon | .a | 42 to 817 | 1 to 777 | 777/782 (99 %) | 10 diff (98.8 %id) | |||
BG546883 | lung | .a | 32 to 801 | 1 to 767 | 767/768 (99 %) | 14 diff (98.2 %id) | |||
BG715050 | brain, hypothalamus | .a | 25 to 824 | 1 to 801 | 801/803 (99 %) | 13 diff (98.4 %id) | |||
BG756077 | B-cells, primary B-cells from tonsils (cell line) | .a | 713 to 1201 | 1 to 488 | AAA | 488/488 (100 %) | 2 diff (99.6 %id) | ||
BG829426 | epithelioid carcinoma cell line, Pancreas | .a | 45 to 877 | 1 to 841 | A161D P196T G197R E199* | 841/846 (99 %) | 18 diff (97.9 %id) | ||
BI223510 | cervical carcinoma cell line, cervix | .a | 928 to 1201 | 25 to 298 | AAA | 274/298 (91 %) | 6 diff (98.0 %id) | ||
BI752214 | brain | .a | 1010 to 1201 | 1 to 191 | AAA | 191/191 (100 %) | 2 diff (99.0 %id) | ||
BI753849 | brain | .a | 40 to 815 | 1 to 782 | 782/782 (100 %) | 9 diff (98.9 %id) | |||
BI770460 | pooled lung and spleen | .a | 56 to 818 | 1 to 778 | 778/778 (100 %) | 38 diff (95.2 %id) | |||
BM558458 | duodenal adenocarcinoma, cell line, small intestine | .a | 67 to 1030 | 1 to 986 | T31A L170A E171R L173P F174V ... | 986/1062 (92 %) | 39 diff (96.4 %id) | ||
BM919292 | pooled pancreas and spleen | .a | 621 to 1201 | 19 to 599 | AAA | 581/599 (96 %) | 6 diff (99.0 %id) | ||
BM923629 | pooled colon, kidney, stomach | .a | 40 to 992 | 7 to 967 | A82P W187X G197X D200G G201W ... | 961/1023 (93 %) | 27 diff (97.4 %id) | ||
BQ182938 | Chondrosarcoma, Left Pubic Bone | .a | 523 to 1201 | 697 to 19 | AAA | 679/679 (100 %) | 1 diff (99.9 %id) | ||
BQ433568 | epithelioid carcinoma, Pancreas | .a | 54 to 875 | 1 to 829 | G169W L170A E171* | 829/868 (95 %) | 10 diff (98.9 %id) | ||
BU078730 | Pancreas, Purified pancreatic islet | .a | 757 to 1202 | 446 to 1 | 446/446 (100 %) | 0 diff (100 %id) | |||
BU079003 | Pancreas, Purified pancreatic islet | .a | 52 to 517 | 1 to 466 | 466/466 (100 %) | 4 diff (99.2 %id) | |||
CK902537 | Pancreas, Purified pancreatic islet | .a | 87 to 608 | 1 to 522 | Submitted on the opposite strand | 522/522 (100 %) | 2 diff (99.7 %id) | ||
BU174579 | ductal carcinoma, cell line, Pancreas | .a | 58 to 633 | 1 to 584 | 584/869 (67 %) | 19 diff (97.9 %id) | |||
BQ878247 | ductal carcinoma, cell line, Pancreas | .a | 61 to 878 | 1 to 824 | K204Q E209G L210A D211G E212P ... | 824/883 (93 %) | 23 diff (97.4 %id) | ||
BQ690528 | ductal carcinoma, cell line, Pancreas | .a | 62 to 884 | 1 to 839 | E199* | 839/878 (95 %) | 22 diff (97.5 %id) | ||
BQ690477 | ductal carcinoma, cell line, Pancreas | .a | 62 to 829 | 1 to 774 | 774/882 (87 %) | 15 diff (98.3 %id) | |||
BQ691598 | ductal carcinoma, cell line, Pancreas | .a | 62 to 560 | 1 to 511 | 511/1000 (51 %) | 27 diff (97.3 %id) | |||
CB178345 | Pancreas, Purified pancreatic islet | .a | 161 to 562 | 1 to 406 | 406/499 (81 %) | 32 diff (93.6 %id) | |||
BU537987 | adenocarcinoma, cell line, breast | .a | 454 to 1201 | 1 to 747 | AAA | 747/747 (100 %) | 2 diff (99.8 %id) | ||
BU538362 | adenocarcinoma, cell line, breast | .a | 454 to 1201 | 1 to 746 | AAA | 746/746 (100 %) | 4 diff (99.5 %id) | ||
BU539198 | adenocarcinoma, cell line, breast | .a | 454 to 1201 | 1 to 748 | AAA | 748/748 (100 %) | 1 diff (99.9 %id) | ||
BU856974 | adenocarcinoma, cell line, breast | .a | 373 to 1201 | 1 to 832 | AAA | 832/838 (99 %) | 6 diff (99.3 %id) | ||
BU957038 | adenocarcinoma, cell line, breast | .a | 396 to 1135 | 1 to 746 | 746/952 (78 %) | 13 diff (98.7 %id) | |||
BU957131 | adenocarcinoma, cell line, breast | .a | 454 to 1201 | 1 to 748 | AAA | 748/748 (100 %) | 4 diff (99.5 %id) | ||
BU957431 | adenocarcinoma, cell line, breast | .a | 371 to 1182 | 1 to 822 | 822/949 (86 %) | 19 diff (98.0 %id) | |||
CF453984 | peripheral nervous system | .a | 45 to 766 | 1 to 722 | 722/722 (100 %) | 3 diff (99.6 %id) | |||
TI_57218962 | .a | 40 to 815 | 28 to 809 | 782/809 (96 %) | 14 diff (98.3 %id) | ||||
TI_57179730 | .a | 56 to 818 | 29 to 806 | 778/806 (96 %) | 37 diff (95.5 %id) | ||||
CB147576 | Liver | .a | 33 to 449 | 1 to 417 | 417/417 (100 %) | 6 diff (98.6 %id) | |||
CB141964 | Liver | .a | 33 to 495 | 1 to 463 | 463/463 (100 %) | 6 diff (98.8 %id) | |||
DA646019 | mammary gland | .a | 1 to 690 | 2 to 689 | capped | 688/695 (98 %) | 8 diff (98.9 %id) | ||
DB360648 | mammary gland | .a | 1559 to 2113 | 556 to 1 | tiling clone, | 556/558 (99 %) | 11 diff (98.1 %id) | ||
DA671660 | .a | 31 to 609 | 2 to 580 | capped | 579/579 (100 %) | 1 diff (99.9 %id) | |||
NM_013376.3 | .a | 1 to 1201 | 2 to 1202 | exact | RefSeq, AAA | 1202/1202 (100 %) | 1 diff (100.0 %id) | ||
CR987997 | T-Lymphocytes | .a | 45 to 609 | 1 to 566 | 566/568 (99 %) | 7 diff (98.8 %id) | |||
CR997336 | T-Lymphocytes | .a | 45 to 631 | 1 to 590 | 590/610 (96 %) | 3 diff (99.6 %id) | |||
CT003156 | T-Lymphocytes | .a | 795 to 1201 | 1 to 408 | 408/408 (100 %) | 2 diff (99.6 %id) | |||
BM838521 | Ascites, stomach | .a | 35 to 570 | 1 to 536 | 536/536 (100 %) | 1 diff (99.9 %id) | |||
BM822137 | stomach | .a | 33 to 140 | 1 to 107 | 107/107 (100 %) | 3 diff (97.2 %id) | |||
BM843483 | lymph node, stomach | .a | 32 to 658 | 1 to 627 | 627/627 (100 %) | 3 diff (99.6 %id) | |||
TI_1948100947 | .a | 383 to 868 | 611 to 126 | 486/1349 (36 %) | 0 diff (100 %id) | ||||
DN990289 | brain, whole brain | .a | 50 to 613 | 1 to 564 | 564/564 (100 %) | 5 diff (99.2 %id) | |||
TI_149290196 | .a | 462 to 1201 | 795 to 63 | AAA | 733/818 (89 %) | 13 diff (98.5 %id) | |||
TI_154061849 | .a | 268 to 1201 | 1052 to 127 | AAA | 926/994 (93 %) | 10 diff (99.0 %id) | |||
TI_154110575 | .a | 241 to 1201 | 1033 to 80 | AAA | 954/987 (96 %) | 20 diff (98.0 %id) | |||
TI_157601723 | .a | 318 to 1201 | 964 to 88 | AAA | 877/878 (99 %) | 29 diff (96.7 %id) | |||
TI_159714806 | .a | 406 to 1201 | 861 to 74 | AAA | 788/993 (79 %) | 23 diff (97.7 %id) | |||
TI_227714187 | .a | 224 to 1201 | 1064 to 86 | AAA | 979/980 (99 %) | 18 diff (98.2 %id) | |||
CF529288 | placenta | .a | 600 to 1201 | 620 to 19 | AAA | 602/602 (100 %) | 1 diff (99.9 %id) | ||
BM973302 | lung | .a | 523 to 1201 | 695 to 19 | AAA | 677/677 (100 %) | 4 diff (99.5 %id) | ||
CB851800 | Human Lung Epithelial cells, lung | .a | 564 to 1201 | 656 to 19 | AAA | 638/638 (100 %) | 0 diff (100 %id) | ||
CA311446 | Human Lung Epithelial cells, lung | .a | 746 to 1201 | 474 to 19 | AAA | 456/456 (100 %) | 2 diff (99.6 %id) | ||
CB250543 | Human Lung Epithelial cells, lung | .a | 558 to 1201 | 662 to 19 | AAA | 644/644 (100 %) | 5 diff (99.3 %id) | ||
BM673506 | eye, eye anterior segment | .a | 929 to 1201 | 291 to 19 | fully sequenced, AAA | 273/273 (100 %) | 0 diff (100 %id) | ||
BM707405 | eye, eye anterior segment | .a | 691 to 959 | 10 to 278 | fully sequenced, | 269/278 (96 %) | 1 diff (99.7 %id) | ||
BQ771685 | Chondrosarcoma Grade II, Left Pelvis | .a | 543 to 1201 | 674 to 19 | AAA | 656/656 (100 %) | 5 diff (99.3 %id) | ||
CA420820 | Bone, Enchondroma cell line | .a | 554 to 1201 | 666 to 19 | AAA | 648/648 (100 %) | 1 diff (99.9 %id) | ||
CA431558 | cell lines, Enchondroma | .a | 542 to 1201 | 677 to 19 | AAA | 659/659 (100 %) | 3 diff (99.6 %id) | ||
BU621368 | cell lines, Chondrosarcoma | .a | 811 to 1201 | 409 to 19 | AAA | 391/391 (100 %) | 4 diff (99.0 %id) | ||
BU633212 | cell lines, Chondrosarcoma | .a | 523 to 1201 | 698 to 19 | AAA | 680/680 (100 %) | 1 diff (99.9 %id) | ||
CA748763 | Alveolar Macrophage, lung | .a | 488 to 1201 | 732 to 19 | AAA | 714/714 (100 %) | 4 diff (99.5 %id) | ||
CD368900 | Alveolar Macrophage, lung | .a | 576 to 1201 | 645 to 19 | AAA | 627/627 (100 %) | 10 diff (98.5 %id) | ||
CD364905 | Alveolar Macrophage, lung | .a | 473 to 1201 | 747 to 19 | AAA | 729/729 (100 %) | 0 diff (100 %id) | ||
BP376053 | uterus | .a | 711 to 1201 | 1 to 491 | AAA | 491/491 (100 %) | 0 diff (100 %id) | ||
BQ690477 | ductal carcinoma, cell line, Pancreas | .a | 62 to 829 | 1 to 774 | 774/882 (87 %) | 15 diff (98.3 %id) | |||
BQ691598 | ductal carcinoma, cell line, Pancreas | .a | 62 to 560 | 1 to 511 | 511/1000 (51 %) | 27 diff (97.3 %id) | |||
BQ691598 | IMAGE:6251758 | SERTAD1.aAug10 | 560 | 511 | IMAGE:6251758 | 511 | 27 | ||
CB178345 | IMAGE:6554675 | SERTAD1.aAug10 | 562 | 406 | IMAGE:6554675 | 406 | 32 | ||
CB178345 | IMAGE:6554675 | SERTAD1.aAug10 | 562 | 406 | IMAGE:6554675 | 406 | 32 | ||
BU537987 | IMAGE:6568492 | SERTAD1.aAug10 | 1201 | 747 | IMAGE:6568492 | 747 | 2 | ||
BU537987 | IMAGE:6568492 | SERTAD1.aAug10 | 1201 | 747 | IMAGE:6568492 | 747 | 2 | ||
BU538362 | IMAGE:6568905 | SERTAD1.aAug10 | 1201 | 746 | IMAGE:6568905 | 746 | 4 | ||
BU538362 | IMAGE:6568905 | SERTAD1.aAug10 | 1201 | 746 | IMAGE:6568905 | 746 | 4 | ||
BU539198 | IMAGE:6569886 | SERTAD1.aAug10 | 1201 | 748 | IMAGE:6569886 | 748 | 1 | ||
BU539198 | IMAGE:6569886 | SERTAD1.aAug10 | 1201 | 748 | IMAGE:6569886 | 748 | 1 | ||
BU856974 | IMAGE:6646774 | SERTAD1.aAug10 | 1201 | 832 | IMAGE:6646774 | 832 | 6 | ||
BU856974 | IMAGE:6646774 | SERTAD1.aAug10 | 1201 | 832 | IMAGE:6646774 | 832 | 6 | ||
BU957038 | IMAGE:6730990 | SERTAD1.aAug10 | 1135 | 746 | IMAGE:6730990 | 746 | 13 | ||
BU957038 | IMAGE:6730990 | SERTAD1.aAug10 | 1135 | 746 | IMAGE:6730990 | 746 | 13 | ||
BU957131 | IMAGE:6731093 | SERTAD1.aAug10 | 1201 | 748 | IMAGE:6731093 | 748 | 4 | ||
BU957131 | IMAGE:6731093 | SERTAD1.aAug10 | 1201 | 748 | IMAGE:6731093 | 748 | 4 | ||
BU957431 | IMAGE:6731456 | SERTAD1.aAug10 | 1182 | 822 | IMAGE:6731456 | 822 | 19 | ||
BU957431 | IMAGE:6731456 | SERTAD1.aAug10 | 1182 | 822 | IMAGE:6731456 | 822 | 19 | ||
CF453984 | IMAGE:30513424 | SERTAD1.aAug10 | 766 | 722 | IMAGE:30513424 | 722 | 3 | ||
TI_57218962 | INCYTE_603027530 | SERTAD1.aAug10 | 815 | 809 | INCYTE_603027530 | 782 | 14 | ||
TI_57179730 | INCYTE_603055426 | SERTAD1.aAug10 | 818 | 806 | INCYTE_603055426 | 778 | 37 | ||
CB147576 | L11SNU354s1-29-E01 | SERTAD1.aAug10 | 449 | 417 | L11SNU354s1-29-E01 | 417 | 6 | ||
CB141964 | L11SNU354s1-31-C04 | SERTAD1.aAug10 | 495 | 463 | L11SNU354s1-31-C04 | 463 | 6 | ||
DA646019 | MAMMA1000403 | SERTAD1.aAug10 | 690 | 689 | MAMMA1000403 | 688 | 8 | ||
DB360648 | MAMMA1000403 | SERTAD1.aAug10 | 2113 | 1 | MAMMA1000403 | 556 | 11 | ||
DA671660 | NETRP2001975 | SERTAD1.aAug10 | 609 | 580 | NETRP2001975 | 579 | 1 | ||
NM_013376.3 | NM_013376 | SERTAD1.aAug10 | 1201 | 1202 | NM_013376 | 1202 | 1 | ||
CR987997 | RZPDp9016E0743 | SERTAD1.aAug10 | 609 | 566 | RZPDp9016E0743 | 566 | 7 | ||
CR997336 | RZPDp9016M0524 | SERTAD1.aAug10 | 631 | 590 | RZPDp9016M0524 | 590 | 3 | ||
CT003156 | RZPDp9017G2225 | SERTAD1.aAug10 | 1201 | 408 | RZPDp9017G2225 | 408 | 2 | ||
BM838521 | S9SNU601-94-H02 | SERTAD1.aAug10 | 570 | 536 | S9SNU601-94-H02 | 536 | 1 | ||
BM838521 | S9SNU601-94-H02 | SERTAD1.aAug10 | 570 | 536 | S9SNU601-94-H02 | 536 | 1 | ||
BM822137 | S11SNU1-37-A05 | SERTAD1.aAug10 | 140 | 107 | S11SNU1-37-A05 | 107 | 3 | ||
BM843483 | S12SNU216-87-H03 | SERTAD1.aAug10 | 658 | 627 | S12SNU216-87-H03 | 627 | 3 | ||
BM843483 | S12SNU216-87-H03 | SERTAD1.aAug10 | 658 | 627 | S12SNU216-87-H03 | 627 | 3 | ||
TI_1948100947 | SC_11047_1_A8 | SERTAD1.aAug10 | 868 | 126 | SC_11047_1_A8 | 486 | 0 | ||
DN990289 | TC108621 | SERTAD1.aAug10 | 613 | 564 | TC108621 | 564 | 5 | ||
DN990289 | TC108621 | SERTAD1.aAug10 | 613 | 564 | TC108621 | 564 | 5 | ||
TI_149290196 | TI_149290196 | SERTAD1.aAug10 | 1201 | 63 | TI_149290196 | 733 | 13 | ||
TI_154061849 | TI_154061849 | SERTAD1.aAug10 | 1201 | 127 | TI_154061849 | 926 | 10 | ||
TI_154110575 | TI_154110575 | SERTAD1.aAug10 | 1201 | 80 | TI_154110575 | 954 | 20 | ||
TI_157601723 | TI_157601723 | SERTAD1.aAug10 | 1201 | 88 | TI_157601723 | 877 | 29 | ||
TI_159714806 | TI_159714806 | SERTAD1.aAug10 | 1201 | 74 | TI_159714806 | 788 | 23 | ||
TI_227714187 | TI_227714187 | SERTAD1.aAug10 | 1201 | 86 | TI_227714187 | 979 | 18 | ||
CF529288 | UI-1-BC1p-ata-f-05-0-UI | SERTAD1.aAug10 | 1201 | 19 | UI-1-BC1p-ata-f-05-0-UI | 602 | 1 | ||
BM973302 | UI-CF-EC1-abx-a-23-0-UI | SERTAD1.aAug10 | 1201 | 19 | UI-CF-EC1-abx-a-23-0-UI | 677 | 4 | ||
CB851800 | UI-CF-FN0-aen-k-23-0-UI | SERTAD1.aAug10 | 1201 | 19 | UI-CF-FN0-aen-k-23-0-UI | 638 | 0 | ||
CB851800 | UI-CF-FN0-aen-k-23-0-UI | SERTAD1.aAug10 | 1201 | 19 | UI-CF-FN0-aen-k-23-0-UI | 638 | 0 | ||
CA311446 | UI-CF-FN0-afd-e-17-0-UI | SERTAD1.aAug10 | 1201 | 19 | UI-CF-FN0-afd-e-17-0-UI | 456 | 2 | ||
CA311446 | UI-CF-FN0-afd-e-17-0-UI | SERTAD1.aAug10 | 1201 | 19 | UI-CF-FN0-afd-e-17-0-UI | 456 | 2 | ||
CB250543 | UI-CF-FN0-age-p-09-0-UI | SERTAD1.aAug10 | 1201 | 19 | UI-CF-FN0-age-p-09-0-UI | 644 | 5 | ||
CB250543 | UI-CF-FN0-age-p-09-0-UI | SERTAD1.aAug10 | 1201 | 19 | UI-CF-FN0-age-p-09-0-UI | 644 | 5 | ||
BM673506 | UI-E-CR1-aef-h-04-0-UI | SERTAD1.aAug10 | 1201 | 19 | UI-E-CR1-aef-h-04-0-UI | 273 | 0 | ||
BM673506 | UI-E-CR1-aef-h-04-0-UI | SERTAD1.aAug10 | 1201 | 19 | UI-E-CR1-aef-h-04-0-UI | 273 | 0 | ||
BM707405 | UI-E-CR1-aef-h-04-0-UI | SERTAD1.aAug10 | 959 | 278 | UI-E-CR1-aef-h-04-0-UI | 269 | 1 | ||
BM707405 | UI-E-CR1-aef-h-04-0-UI | SERTAD1.aAug10 | 959 | 278 | UI-E-CR1-aef-h-04-0-UI | 269 | 1 | ||
BQ771685 | UI-H-EZ1-bbj-n-17-0-UI | SERTAD1.aAug10 | 1201 | 19 | UI-H-EZ1-bbj-n-17-0-UI | 656 | 5 | ||
BQ771685 | UI-H-EZ1-bbj-n-17-0-UI | SERTAD1.aAug10 | 1201 | 19 | UI-H-EZ1-bbj-n-17-0-UI | 656 | 5 | ||
CA420820 | UI-H-FG0-bcr-c-07-0-UI | SERTAD1.aAug10 | 1201 | 19 | UI-H-FG0-bcr-c-07-0-UI | 648 | 1 | ||
CA420820 | UI-H-FG0-bcr-c-07-0-UI | SERTAD1.aAug10 | 1201 | 19 | UI-H-FG0-bcr-c-07-0-UI | 648 | 1 | ||
CA431558 | UI-H-FG1-bgq-f-16-0-UI | SERTAD1.aAug10 | 1201 | 19 | UI-H-FG1-bgq-f-16-0-UI | 659 | 3 | ||
CA431558 | UI-H-FG1-bgq-f-16-0-UI | SERTAD1.aAug10 | 1201 | 19 | UI-H-FG1-bgq-f-16-0-UI | 659 | 3 | ||
BU621368 | UI-H-FL1-bfz-h-04-0-UI | SERTAD1.aAug10 | 1201 | 19 | UI-H-FL1-bfz-h-04-0-UI | 391 | 4 | ||
BU621368 | UI-H-FL1-bfz-h-04-0-UI | SERTAD1.aAug10 | 1201 | 19 | UI-H-FL1-bfz-h-04-0-UI | 391 | 4 | ||
BU633212 | UI-H-FL1-bgt-f-24-0-UI | SERTAD1.aAug10 | 1201 | 19 | UI-H-FL1-bgt-f-24-0-UI | 680 | 1 | ||
BU633212 | UI-H-FL1-bgt-f-24-0-UI | SERTAD1.aAug10 | 1201 | 19 | UI-H-FL1-bgt-f-24-0-UI | 680 | 1 | ||
CA748763 | UI-H-FT1-bhy-p-10-0-UI | SERTAD1.aAug10 | 1201 | 19 | UI-H-FT1-bhy-p-10-0-UI | 714 | 4 | ||
CA748763 | UI-H-FT1-bhy-p-10-0-UI | SERTAD1.aAug10 | 1201 | 19 | UI-H-FT1-bhy-p-10-0-UI | 714 | 4 | ||
CD368900 | UI-H-FT1-bjx-f-15-0-UI | SERTAD1.aAug10 | 1201 | 19 | UI-H-FT1-bjx-f-15-0-UI | 627 | 10 | ||
CD368900 | UI-H-FT1-bjx-f-15-0-UI | SERTAD1.aAug10 | 1201 | 19 | UI-H-FT1-bjx-f-15-0-UI | 627 | 10 | ||
CD364905 | UI-H-FT2-bjn-c-13-0-UI | SERTAD1.aAug10 | 1201 | 19 | UI-H-FT2-bjn-c-13-0-UI | 729 | 0 | ||
CD364905 | UI-H-FT2-bjn-c-13-0-UI | SERTAD1.aAug10 | 1201 | 19 | UI-H-FT2-bjn-c-13-0-UI | 729 | 0 | ||
BP376053 | WMC02586 | SERTAD1.aAug10 | 1201 | 491 | WMC02586 | 491 | 0 |